MedTech, Industrial Impact

Bispecific Antibodies - CMC Considerations

December 16, 2022

Bispecific Antibodies
Bispecific antibodies (bsAbs) are genetically engineered, recombinant antibodies that consist of two distinct binding domains.

Spotlight

Sequence Inc.

Sequence is a leader in providing quality and compliance services to the Pharmaceutical, Biotech, and Cell & Gene Therapy industries. United with our clients, we work together to provide services that result in products of the highest quality. Through our knowledge, experience, and integrity we strive to offer a level of service that is unsurpassed industry wide.

OTHER WHITEPAPERS
news image

2022 Biosimilars Report: The U.S. Journey and Path Ahead

whitePaper | June 8, 2022

Cardinal Health is fortunate to sit at the crossroads of the United States (U.S.) healthcare system, engaging with stakeholders from across the industry including healthcare

Read More
news image

HIGH THROUGHPUT AAV VIRAL TITERING USING NANOPLATE-BASED DIGITAL PCR

whitePaper | December 22, 2022

Determining the physical titer of viral vectors has typically been accomplished using digital droplet PCR (ddPCR). Droplet-based methods, however, are challenged by matrix effects and long analysis times (up to 7 hours).

Read More
news image

70 years of wood modifcation with fungi

whitePaper | March 18, 2022

Fungi are usually seen by the wood used only as destroyers or parasites. Material infestation should be avoided as far as possible for wood preservation reasons.

Read More
news image

Making the Promise of mRNA a Reality: OvercomingScale-Up Challenges

whitePaper | March 22, 2023

If scaling issues strike you as obvious or even boring, you should read “On Being the Right Size,” a 1926 essay by geneticist J.B.S. Haldane. It makes the case that a difference in scale—a seemingly simple matter—may demand subtle changes in form and function.

Read More
news image

Risk assessment of fungal materials

whitePaper | February 24, 2022

Sustainable fungal materials have a high potential to replace non-sustainable materials such as those used for packaging or as an alternative for leather and textile.

Read More
news image

Leveraging innovations in plasmid manufacturing to bring advanced therapies to market

whitePaper | December 13, 2022

The global demand for plasmid DNA has increased dramatically in recent years, fueled by a surge in the clinical development of next-generation cell and gene therapy products and more recently by the success of COVID-19 vaccines.

Read More

Spotlight

Sequence Inc.

Sequence is a leader in providing quality and compliance services to the Pharmaceutical, Biotech, and Cell & Gene Therapy industries. United with our clients, we work together to provide services that result in products of the highest quality. Through our knowledge, experience, and integrity we strive to offer a level of service that is unsurpassed industry wide.

Events